Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Aug 2;19(1):37.
doi: 10.1186/s12981-022-00461-4.

What is polypharmacy in people living with HIV/AIDS? A systematic review

Affiliations
Meta-Analysis

What is polypharmacy in people living with HIV/AIDS? A systematic review

Mohammed Ibn-Mas'ud Danjuma et al. AIDS Res Ther. .

Abstract

Polypharmacy in people living with HIV/AIDS (PLWHA) is a rising morbidity that exacts hefty economic burden on health budgets in addition to other adverse clinical outcomes. Despite recent advances, uncertainty remains around its exact definition in PLWHA. In this systematic review and Meta-analysis, we explored relevant databases (PUBMED, EMBASE, CROI) for studies evaluating polypharmacy in PLWHA from January 2000 to August 2021 to ascertain the exact numerical threshold that defines this morbidity. Two independent reviewers extracted and reviewed relevant variables for analyses. The review included a total of 31 studies involving n = 53,347 participants with a mean age of 49.5 (SD ± 17.0) years. There was a total of 36 definitions, with 93.5% defining polypharmacy as the concomitant use of 5 or more medications. We found significant variation in the numerical definition of polypharmacy, with studies reporting it as "minor" (N = 3); "major" (N = 29); "severe" (N = 2); "excessive" (N = 1); and "higher" (N = 1). Most studies did not incorporate a duration (84%) in their definition and excluded ART medications (67.7%). A plurality of studies in PLWHA have established that polypharmacy in this cohort of patients is the intake of ≥ 5 medications (including both ART and non-ART). To standardize the approach to addressing this rising morbidity, we recommend incorporation of this definition into national and international PLWHA treatment guidelines.

Keywords: AIDS; Antiretroviral; Drug interactions; HIV; PLWHA; Polypharmacy.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any competing interests to declare.

Figures

Fig. 1
Fig. 1
PRISMA flow chart for study selection
Fig. 2
Fig. 2
Map showing the distribution of studies included in the review. (Spain = 7; Italy = 3; Ireland = 1; USA = 5; Turkey = 1; Canada = 3: UK = 5; Mexico = 1; Australia = 1; Brazil = 1; Switzerland = 1)

Similar articles

Cited by

References

    1. Back D, Marzolini C. The challenge of HIV treatment in an era of polypharmacy. J Int AIDS Soc. 2020;23(2):e25449. doi: 10.1002/jia2.25449. - DOI - PMC - PubMed
    1. Guaraldi G, Malagoli A, Calcagno A, Mussi C, Celesia BM, Carli F, Piconi S, De Socio GV, Cattelan AM, Orofino G. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65–74 years and more than 75 years. BMC Geriatr. 2018;18(1):99. doi: 10.1186/s12877-018-0789-0. - DOI - PMC - PubMed
    1. Sullivan PS, Satcher Johnson A, Pembleton ES, Stephenson R, Justice AC, Althoff KN, Bradley H, Castel AD, Oster AM, Rosenberg ES, Mayer KH, Beyrer C. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. Lancet. 2021;397(10279):1095–1106. doi: 10.1016/S0140-6736(21)00395-0. - DOI - PubMed
    1. Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–1196. doi: 10.1080/14740338.2018.1546841. - DOI - PubMed
    1. McIsaac DI, Wong CA, Bryson GL, van Walraven C. Association of polypharmacy with survival, complications, and healthcare resource use after elective noncardiac surgery: a population-based cohort study. Anesthesiol J Am Soc Anesthesiol. 2018;128(6):1140–1150. - PubMed